RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions Blog Post
Speakers: Evan Richardson Senior Director, Regulatory Operations and Clinical Disclosure, Certara A seasoned pharmaceutical industry veteran, Evans Richardson brings nearly 20 years of experience spanning drugs, biologics, and medical devices....
Applications of Quantitative Systems Pharmacology Modeling for Vaccine Development Blog Post
Vaccines play a crucial role in preventing diseases and thereby saving countless lives. To prevent the spread of diseases, it is important that vaccines are broadly available in all parts...
IUPHAR review: Computational Psychiatry 2.0. A new tool for supporting combination therapy of psychopharmacology with neuromodulation in schizophrenia Blog Post
Publication: Journal of Pharmacokinetics and Pharmacodynamics Abstract Recent clinical trial successes in schizophrenia with non-dopaminergic agents have rejuvenated the field after a long period of unsuccessful attempts. At the same...
Streamlining Population PK Modeling with Phoenix NLME & Pirana: Bridging Efficiency and Precision in Pharmacometrics [APAC Webinar] Blog Post
Speaker: Keith Nieforth, PharmD Senior Director, Pharmacometric Software, Certara Keith has more than 20 years of global drug development experience. Prior to joining Certara, Keith held a variety of positions...
SEND V4.0 – What to Expect and When to Expect It Blog Post
Peggy Zorn April 24, 2025 As the Standard for Exchange of Nonclinical Data (SEND) continues to evolve in both scope and complexity, the upcoming release of SEND 4.0 marks a...
Best Practices for AI Prompt Engineering in Life Sciences Blog Post
Ian Kerman April 23, 2025 Prompt engineering is an emerging skill introduced to the public with the launch of ChatGPT by OpenAI in 20221. Although the hype around prompt engineering...
Certara Announces Second Annual Certainty U.S. Event Blog Post
Certara’s premier client conference explores how in-silico methods and biosimulation at scale derisk every stage of development, from market to molecule RADNOR, PA – April 22, 2025 – Certara, Inc....
NAM Strategies Page
Tailored NAM strategies to reduce animal use, support global regulatory alignment, and accelerate your drug development program with expert guidance.
Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug–Drug Interactions Blog Post
June 17, 2025 – 11am ET
